Development and evaluation of biological reagents targetting and inhibiting function of the EphA3 receptor on tumour cells

  • Lackmann, Martin, (Primary Chief Investigator (PCI))
  • Lee, Fook-Thean (Chief Investigator (CI))
  • Scott, Andrew (Chief Investigator (CI))

Project: Research

StatusFinished
Effective start/end date1/04/0331/12/05

Funding

  • National Health & Medical Research Council (NHMRC): AUD465,000.00